` 8622 (Huakang Biomedical Holdings Co Ltd) vs Hang Seng (Hong Kong) Comparison - Alpha Spread

8622
vs
Hang Seng (Hong Kong)

Over the past 12 months, has underperformed Hang Seng (Hong Kong), delivering a return of 18% compared to the Hang Seng (Hong Kong)'s 20% growth.

Stocks Performance
8622 vs Hang Seng (Hong Kong)

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
8622 vs Hang Seng (Hong Kong)

Loading
8622
Hang Seng (Hong Kong)
Difference

Performance By Year
8622 vs Hang Seng (Hong Kong)

Loading
8622
Hang Seng (Hong Kong)
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Huakang Biomedical Holdings Co Ltd vs Peers

Hang Seng (Hong Kong)
8622
7741
ALC
COLO B
ALGN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Huakang Biomedical Holdings Co Ltd
Glance View

Market Cap
88.1m HKD
Industry
Health Care

Huakang Biomedical Holdings Co. Ltd. operates as a medical group company. The company employs 83 full-time employees The company went IPO on 2018-12-13. The IVD reagents include male fertility IVD reagents, Epstein-Barr virus antibody detection reagents ad parasite antibody detection reagents, among others. The male fertility IVD reagents include sperm function test products, accessory genital glands test products, anti-sperm antibody test products, as well as male reproductive tract infection test products, among others. In addition, the Company is also involved in the sale of auxiliary reproductive supplies and equipments, such as glass coverslips and sperm sample collection cups.

Intrinsic Value
0.085 HKD
Overvaluation 52%
Intrinsic Value
Price
H
Back to Top